Limits...
Recent epidemiological trends of dengue in the French territories of the Americas (2000-2012): a systematic literature review.

L'Azou M, Taurel AF, Flamand C, Quénel P - PLoS Negl Trop Dis (2014)

Bottom Line: Substantial gaps in epidemiological knowledge were identified.Additionally, much of the available data were from epidemic years; data from inter-epidemic periods were sparse.PROSPERO CRD42012002341.

View Article: PubMed Central - PubMed

Affiliation: Global Epidemiology Department, Sanofi Pasteur, Lyon, France.

ABSTRACT

Unlabelled: Dengue is a public health concern across the globe, and an escalating problem in the Americas. As part of a wider programme (covering Latin America and South East Asia) to characterize the epidemiology of dengue in dengue endemic areas, we undertook a systematic literature review to assess epidemiological trends (incidence, timing and duration of outbreaks/epidemics, age and sex distribution, serotype distribution, seroprevalence and disease severity) for dengue across the French Territories of the Americas (FTA), in French Guiana, Guadeloupe, Martinique, Saint Martin and Saint Barthélemy between 2000 and 2012 (CRD42012002341: http://www.crd.york.ac.uk/prospero/display_record.asp?ID=CRD42012002341). Of 413 relevant data sources identified, 45 were eligible for inclusion. A large proportion of the available data were from national surveillance reports, and 12 publications were from peer-reviewed journals. During the review period, 3-5 epidemics were identified in each of the island territories and French Guiana, and epidemics were often associated with a shift in the predominant circulating dengue virus serotype. Substantial gaps in epidemiological knowledge were identified. In particular, information regarding dengue virus genotype distribution, seroprevalence and age distribution of dengue were lacking. Additionally, much of the available data were from epidemic years; data from inter-epidemic periods were sparse. Nevertheless, the available epidemiological data showed that dengue is endemic across the FTA and suggest an evolution towards hyperendemicity, highlighting the need to continue the efforts with the existing surveillance programmes to assist in planning an effective vaccination programme once a dengue vaccine is deployed.

Protocol registration: PROSPERO CRD42012002341.

No MeSH data available.


Related in: MedlinePlus

Distribution of dengue virus serotypes in (A) French Guiana, (B) Martinique and (C) Guadeloupe, 2000–2011.All four DENV serotypes have been in circulation in French Guiana and Martinique throughout the review period and from 2005 in Guadeloupe. The predominant serotypes varied over time, and shifts in predominant serotypes were concomitant with the reported epidemics. In all three territories, more than one DENV serotype was usually in circulation at any one time. In French Guiana co-circulation of all four serotypes was observed during the 2004–2005 epidemic, as well as in 2005, 2006 and 2008 and in Martinique, co-circulation of all four serotypes was observed in 2005–2006. (A) French Guiana. Figure reproduced from Quénel P, Rosine J, Cassadou S, Ardillon V, Blateau A, et al. (2011) Epidémiologie de la dengue dans les départements français d'Amérique. Bull Epidemiol Hebd 33–34: 358–363 [13], with permission from Bulletin Epidémiologique Hebdomadaire, Institut de Veille Sanitaire. (B) Martinique. Figure reproduced from Quénel P, Rosine J, Cassadou S, Ardillon V, Blateau A, et al. (2011) Epidémiologie de la dengue dans les départements français d'Amérique. Bull Epidemiol Hebd 33–34: 358–363 [13], with permission from Bulletin Epidémiologique Hebdomadaire, Institut de Veille Sanitaire. (C) Guadeloupe. Figure reproduced from Quénel P, Rosine J, Ardillon V, Cardoso T, Cassadou S, et al. (2008) Vers une hyperendémicité de la dengue dans les Antilles françaises. 9es Journées Nationales d'Infectiologie, 4–6 June 2008, Marseille, France [59], with permission from Philippe Quénel.
© Copyright Policy
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4222734&req=5

pntd-0003235-g003: Distribution of dengue virus serotypes in (A) French Guiana, (B) Martinique and (C) Guadeloupe, 2000–2011.All four DENV serotypes have been in circulation in French Guiana and Martinique throughout the review period and from 2005 in Guadeloupe. The predominant serotypes varied over time, and shifts in predominant serotypes were concomitant with the reported epidemics. In all three territories, more than one DENV serotype was usually in circulation at any one time. In French Guiana co-circulation of all four serotypes was observed during the 2004–2005 epidemic, as well as in 2005, 2006 and 2008 and in Martinique, co-circulation of all four serotypes was observed in 2005–2006. (A) French Guiana. Figure reproduced from Quénel P, Rosine J, Cassadou S, Ardillon V, Blateau A, et al. (2011) Epidémiologie de la dengue dans les départements français d'Amérique. Bull Epidemiol Hebd 33–34: 358–363 [13], with permission from Bulletin Epidémiologique Hebdomadaire, Institut de Veille Sanitaire. (B) Martinique. Figure reproduced from Quénel P, Rosine J, Cassadou S, Ardillon V, Blateau A, et al. (2011) Epidémiologie de la dengue dans les départements français d'Amérique. Bull Epidemiol Hebd 33–34: 358–363 [13], with permission from Bulletin Epidémiologique Hebdomadaire, Institut de Veille Sanitaire. (C) Guadeloupe. Figure reproduced from Quénel P, Rosine J, Ardillon V, Cardoso T, Cassadou S, et al. (2008) Vers une hyperendémicité de la dengue dans les Antilles françaises. 9es Journées Nationales d'Infectiologie, 4–6 June 2008, Marseille, France [59], with permission from Philippe Quénel.

Mentions: All four DENV serotypes have been in circulation in French Guiana throughout the review period (Table S3). The predominant serotypes varied over time, and shifts in predominant serotypes were concomitant with the reported epidemics (Figure 3A). With the exception of 2003 when circulation of DENV-1 was predominant (60%), DENV-1 was present at low levels until 2006 (range: 0.9–4.4%), after which its prevalence increased (range: 22.0–71.7%). During the review period, DENV-2 was not isolated until 2005, it was associated with the 2005–2006 epidemic and was predominant until 2008, after which it fell to low levels (range: 5.4–6.1%). DENV-3 circulated at high levels until 2005 (range: 40.0–98.6%) and was associated with the 2001 and 2004–2005 epidemics [10], after which it fell to low levels (0–4.9%). DENV-4 circulated at low levels from 2004 until 2008 (range: 0–12.3%), increased in 2009 (22.2–22.7%) and became predominant in 2010 (57.2%). Phylogenetic analyses of two DENV-4 strains isolated in French Guiana in 2004 and 2005 showed that they belonged to DENV-4 genotype II [31].


Recent epidemiological trends of dengue in the French territories of the Americas (2000-2012): a systematic literature review.

L'Azou M, Taurel AF, Flamand C, Quénel P - PLoS Negl Trop Dis (2014)

Distribution of dengue virus serotypes in (A) French Guiana, (B) Martinique and (C) Guadeloupe, 2000–2011.All four DENV serotypes have been in circulation in French Guiana and Martinique throughout the review period and from 2005 in Guadeloupe. The predominant serotypes varied over time, and shifts in predominant serotypes were concomitant with the reported epidemics. In all three territories, more than one DENV serotype was usually in circulation at any one time. In French Guiana co-circulation of all four serotypes was observed during the 2004–2005 epidemic, as well as in 2005, 2006 and 2008 and in Martinique, co-circulation of all four serotypes was observed in 2005–2006. (A) French Guiana. Figure reproduced from Quénel P, Rosine J, Cassadou S, Ardillon V, Blateau A, et al. (2011) Epidémiologie de la dengue dans les départements français d'Amérique. Bull Epidemiol Hebd 33–34: 358–363 [13], with permission from Bulletin Epidémiologique Hebdomadaire, Institut de Veille Sanitaire. (B) Martinique. Figure reproduced from Quénel P, Rosine J, Cassadou S, Ardillon V, Blateau A, et al. (2011) Epidémiologie de la dengue dans les départements français d'Amérique. Bull Epidemiol Hebd 33–34: 358–363 [13], with permission from Bulletin Epidémiologique Hebdomadaire, Institut de Veille Sanitaire. (C) Guadeloupe. Figure reproduced from Quénel P, Rosine J, Ardillon V, Cardoso T, Cassadou S, et al. (2008) Vers une hyperendémicité de la dengue dans les Antilles françaises. 9es Journées Nationales d'Infectiologie, 4–6 June 2008, Marseille, France [59], with permission from Philippe Quénel.
© Copyright Policy
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4222734&req=5

pntd-0003235-g003: Distribution of dengue virus serotypes in (A) French Guiana, (B) Martinique and (C) Guadeloupe, 2000–2011.All four DENV serotypes have been in circulation in French Guiana and Martinique throughout the review period and from 2005 in Guadeloupe. The predominant serotypes varied over time, and shifts in predominant serotypes were concomitant with the reported epidemics. In all three territories, more than one DENV serotype was usually in circulation at any one time. In French Guiana co-circulation of all four serotypes was observed during the 2004–2005 epidemic, as well as in 2005, 2006 and 2008 and in Martinique, co-circulation of all four serotypes was observed in 2005–2006. (A) French Guiana. Figure reproduced from Quénel P, Rosine J, Cassadou S, Ardillon V, Blateau A, et al. (2011) Epidémiologie de la dengue dans les départements français d'Amérique. Bull Epidemiol Hebd 33–34: 358–363 [13], with permission from Bulletin Epidémiologique Hebdomadaire, Institut de Veille Sanitaire. (B) Martinique. Figure reproduced from Quénel P, Rosine J, Cassadou S, Ardillon V, Blateau A, et al. (2011) Epidémiologie de la dengue dans les départements français d'Amérique. Bull Epidemiol Hebd 33–34: 358–363 [13], with permission from Bulletin Epidémiologique Hebdomadaire, Institut de Veille Sanitaire. (C) Guadeloupe. Figure reproduced from Quénel P, Rosine J, Ardillon V, Cardoso T, Cassadou S, et al. (2008) Vers une hyperendémicité de la dengue dans les Antilles françaises. 9es Journées Nationales d'Infectiologie, 4–6 June 2008, Marseille, France [59], with permission from Philippe Quénel.
Mentions: All four DENV serotypes have been in circulation in French Guiana throughout the review period (Table S3). The predominant serotypes varied over time, and shifts in predominant serotypes were concomitant with the reported epidemics (Figure 3A). With the exception of 2003 when circulation of DENV-1 was predominant (60%), DENV-1 was present at low levels until 2006 (range: 0.9–4.4%), after which its prevalence increased (range: 22.0–71.7%). During the review period, DENV-2 was not isolated until 2005, it was associated with the 2005–2006 epidemic and was predominant until 2008, after which it fell to low levels (range: 5.4–6.1%). DENV-3 circulated at high levels until 2005 (range: 40.0–98.6%) and was associated with the 2001 and 2004–2005 epidemics [10], after which it fell to low levels (0–4.9%). DENV-4 circulated at low levels from 2004 until 2008 (range: 0–12.3%), increased in 2009 (22.2–22.7%) and became predominant in 2010 (57.2%). Phylogenetic analyses of two DENV-4 strains isolated in French Guiana in 2004 and 2005 showed that they belonged to DENV-4 genotype II [31].

Bottom Line: Substantial gaps in epidemiological knowledge were identified.Additionally, much of the available data were from epidemic years; data from inter-epidemic periods were sparse.PROSPERO CRD42012002341.

View Article: PubMed Central - PubMed

Affiliation: Global Epidemiology Department, Sanofi Pasteur, Lyon, France.

ABSTRACT

Unlabelled: Dengue is a public health concern across the globe, and an escalating problem in the Americas. As part of a wider programme (covering Latin America and South East Asia) to characterize the epidemiology of dengue in dengue endemic areas, we undertook a systematic literature review to assess epidemiological trends (incidence, timing and duration of outbreaks/epidemics, age and sex distribution, serotype distribution, seroprevalence and disease severity) for dengue across the French Territories of the Americas (FTA), in French Guiana, Guadeloupe, Martinique, Saint Martin and Saint Barthélemy between 2000 and 2012 (CRD42012002341: http://www.crd.york.ac.uk/prospero/display_record.asp?ID=CRD42012002341). Of 413 relevant data sources identified, 45 were eligible for inclusion. A large proportion of the available data were from national surveillance reports, and 12 publications were from peer-reviewed journals. During the review period, 3-5 epidemics were identified in each of the island territories and French Guiana, and epidemics were often associated with a shift in the predominant circulating dengue virus serotype. Substantial gaps in epidemiological knowledge were identified. In particular, information regarding dengue virus genotype distribution, seroprevalence and age distribution of dengue were lacking. Additionally, much of the available data were from epidemic years; data from inter-epidemic periods were sparse. Nevertheless, the available epidemiological data showed that dengue is endemic across the FTA and suggest an evolution towards hyperendemicity, highlighting the need to continue the efforts with the existing surveillance programmes to assist in planning an effective vaccination programme once a dengue vaccine is deployed.

Protocol registration: PROSPERO CRD42012002341.

No MeSH data available.


Related in: MedlinePlus